Shamrock Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Shamrock Asset Management's PFE Position: Q3 2019 in Review
Shamrock Asset Management increased its Pfizer (PFE) stake by 22% in Q3 2019, buying an estimated $25.6K and bringing the position to 3,970 shares worth $135K. The position accounts for 0.11% of the portfolio, ranked #96.
Shamrock Asset Management first reported a position in PFE in Q1 2014 and has held it in 23 quarters since. The position peaked at $230K in Q3 2018. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- Shamrock Asset Management held 3,970 shares of Pfizer worth $135K as of Q3 2019.
- Shamrock Asset Management bought 705 Pfizer shares in Q3 2019, an estimated $25.6K.
- Pfizer made up 0.11% of Shamrock Asset Management's portfolio in Q3 2019, its #96 holding.
- Shamrock Asset Management first reported a position in Pfizer in Q1 2014 and has held it in 23 quarters since.
- Shamrock Asset Management's Pfizer position peaked at $230K in Q3 2018.
- 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.